Basic and clinical science posters: Brain function

Basic and clinical science posters: Brain function P49 Recurrent hypoglycaemia increases human primary astrocyte oxygen consumption, fatty acid dependency, and pentose phosphate pathway activityPG WEIGHTMAN POTTER1, JM Vlachaki Walker1, JL Robb1, J Chilton1, R Williamson2, A Randall3, KLJ Ellacott1, C Beall11Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, UK, 2School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK, 3Institute of Biomedical and Clinical Sciences, Hatherly Laboratories, University of Exeter Medical School, Exeter, UKRefer to Oral number A64P50Alzheimer's disease drug Memantine inhibits Adenosine triphosphate (ATP)‐sensitive potassium (KATP) channel activation in hypothalamic GT1‐7 cellsBC HALL1,2, C Beall1,2, AD Randall11Hatherly Laboratories, University of Exeter, Exeter, UK, 2Exeter Medical School, University of Exeter, Exeter, UKAims: KATP channels link cellular energy status to electrical activity in a variety of cell types, including pancreatic beta cells and neurons. In the brain, KATP channels are expressed abundantly in the hypothalamus, playing important roles in the regulation of energy metabolism. Memantine (Mem) is an uncompetitive weak N‐methyl‐D‐aspartate receptor (NMDA) antagonist used to treat Alzheimer's disease. Mem was recently reported to block recombinant KATP channels in the 10‐nM concentration range. This activity was suggested to contribute to Mem's therapeutic efficacy via actions at central nervous system (CNS) synapses. We have investigated the effect of Mem on the endogenous KATP channel conductance in the hypothalamic GT1‐7 cell line.Methods: Patch‐clamp electrophysiology at RT was used to examine whole cell currents after the cell had been dialysed with an ATP‐free pipette solution (ensuring KATP channels were maximally open, termed run‐up), Mem was applied via the perfusate.Results: Application of 100μM Mem after run‐up produced a significant reduction in whole‐cell leak conductance compared with vehicle (G/Gmax: Veh 0.86 ± 0.13 (n = 6), 100μM 0.38 ± 0.18 (n = 6), p < 0.05). Similarly, when Mem (100μM) was applied prior to ATP washout, a significant reduction in maximal conductance was observed at run‐up (nS/pF: Veh 1.06 ± 0.05 (n = 25), Mem 100μM 0.41 ± 0.02 (n = 7), p < 0.001). In both experimental protocols, neither 1μM nor 10μM Mem caused any significant reduction in leak current conductance compared with vehicle.Summary: Memantine reduces the leak conductance elicited by ATP washout in GT1‐7 cells; however, this is weak activity only being ˜60% complete at 100μM. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetic Medicine Wiley

Basic and clinical science posters: Brain function

Free
1 page

Loading next page...
1 Page
 
/lp/wiley/basic-and-clinical-science-posters-brain-function-kbLM8X5ETi
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Diabetic Medicine © 2018 Diabetes UK
ISSN
0742-3071
eISSN
1464-5491
D.O.I.
10.1111/dme.4_13571
Publisher site
See Article on Publisher Site

Abstract

P49 Recurrent hypoglycaemia increases human primary astrocyte oxygen consumption, fatty acid dependency, and pentose phosphate pathway activityPG WEIGHTMAN POTTER1, JM Vlachaki Walker1, JL Robb1, J Chilton1, R Williamson2, A Randall3, KLJ Ellacott1, C Beall11Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, UK, 2School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK, 3Institute of Biomedical and Clinical Sciences, Hatherly Laboratories, University of Exeter Medical School, Exeter, UKRefer to Oral number A64P50Alzheimer's disease drug Memantine inhibits Adenosine triphosphate (ATP)‐sensitive potassium (KATP) channel activation in hypothalamic GT1‐7 cellsBC HALL1,2, C Beall1,2, AD Randall11Hatherly Laboratories, University of Exeter, Exeter, UK, 2Exeter Medical School, University of Exeter, Exeter, UKAims: KATP channels link cellular energy status to electrical activity in a variety of cell types, including pancreatic beta cells and neurons. In the brain, KATP channels are expressed abundantly in the hypothalamus, playing important roles in the regulation of energy metabolism. Memantine (Mem) is an uncompetitive weak N‐methyl‐D‐aspartate receptor (NMDA) antagonist used to treat Alzheimer's disease. Mem was recently reported to block recombinant KATP channels in the 10‐nM concentration range. This activity was suggested to contribute to Mem's therapeutic efficacy via actions at central nervous system (CNS) synapses. We have investigated the effect of Mem on the endogenous KATP channel conductance in the hypothalamic GT1‐7 cell line.Methods: Patch‐clamp electrophysiology at RT was used to examine whole cell currents after the cell had been dialysed with an ATP‐free pipette solution (ensuring KATP channels were maximally open, termed run‐up), Mem was applied via the perfusate.Results: Application of 100μM Mem after run‐up produced a significant reduction in whole‐cell leak conductance compared with vehicle (G/Gmax: Veh 0.86 ± 0.13 (n = 6), 100μM 0.38 ± 0.18 (n = 6), p < 0.05). Similarly, when Mem (100μM) was applied prior to ATP washout, a significant reduction in maximal conductance was observed at run‐up (nS/pF: Veh 1.06 ± 0.05 (n = 25), Mem 100μM 0.41 ± 0.02 (n = 7), p < 0.001). In both experimental protocols, neither 1μM nor 10μM Mem caused any significant reduction in leak current conductance compared with vehicle.Summary: Memantine reduces the leak conductance elicited by ATP washout in GT1‐7 cells; however, this is weak activity only being ˜60% complete at 100μM.

Journal

Diabetic MedicineWiley

Published: Jan 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial